Evidence map›Paper›PMID 29444140›Full record

ArticlePloS one2018

Getting to FP2020: Harnessing the private sector to increase modern contraceptive access and choice in Ethiopia, Nigeria, and DRC.

Christina Riley, Danielle Garfinkel, Katherine Thanel, Keith Esch, Endale Workalemahu, Jennifer Anyanti, Godéfroid Mpanya, Arsène Binanga, Jen Pope, Kim Longfield and 3 more

Abstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Christina RileyPopulation Services International, Washington, D.C., United States of America.ORCID 0000-0002-6167-1284
Danielle GarfinkelPopulation Services International, Washington, D.C., United States of America.
Katherine ThanelPopulation Services International, Washington, D.C., United States of America.
Keith EschPopulation Services International, Washington, D.C., United States of America.
Endale WorkalemahuPopulation Services International-Ethiopia, Addis Ababa, Ethiopia.
Jennifer AnyantiSociety for Family Health, Abuja, Nigeria.
Godéfroid MpanyaAssociation de Santé Familiale, Kinshasa, Democratic Republic of Congo.
Arsène BinangaTulane International, Kinshasa, Democratic Republic of Congo.
Jen PopePopulation Services International, Washington, D.C., United States of America.
Kim LongfieldIndependent consultant, Washington, D.C., United States of America.
Jane BertrandDepartment of Global Health Systems and Development, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, United States of America.
Bryan ShawInstitute for Reproductive Health, Georgetown University, Washington, D.C., United States of America.
FPwatch Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAn estimated 214 million women have unmet need for family planning in developing regions. Improved utilization of the private sector is key to achieving universal access to a range of safe and effective modern contraceptive methods stipulated by FP2020 and SDG commitments. Until now, a lack of market data has limited understanding of the private sector's role in increasing contraceptive coverage and choice.

methodsIn 2015, the FPwatch Project conducted representative outlet surveys in Ethiopia, Nigeria, and DRC using a full census approach in selected administrative areas. Every public and private sector outlet with the potential to sell or distribute modern contraceptives was approached. In outlets with modern contraceptives, product audits and provider interviews assessed contraceptive market composition, availability, and price.

findingsExcluding general retailers, 96% of potential outlets in Ethiopia, 55% in Nigeria, and 41% in DRC had modern contraceptive methods available. In Ethiopia, 41% of modern contraceptive stocking outlets were in the private sector compared with approximately 80% in Nigeria and DRC where drug shops were dominant. Ninety-five percent of private sector outlets in Ethiopia had modern contraceptive methods available; 37% had three or more methods. In Nigeria and DRC, only 54% and 42% of private sector outlets stocked modern contraceptives with 5% and 4% stocking three or more methods, respectively. High prices in Nigeria and DRC create barriers to consumer access and choice. DISCUSSION: There is a missed opportunity to provide modern contraception through the private sector, particularly drug shops. Subsidies and interventions, like social marketing and social franchising, could leverage the private sector's role in increasing access to a range of contraceptives. Achieving global FP2020 commitments depends on the expansion of national contraceptive policies that promote greater partnership and cooperation with the private sector and improvement of decisions around funding streams of countries with large populations and high unmet need like Ethiopia, Nigeria, and DRC.

Indexed as

Choice BehaviorPrivate SectorContraceptive AgentsContraceptive DevicesDemocratic Republic of the CongoEthiopiaFemaleHumansNigeriaContraceptive Agents

Identifiers

PMID29444140
PMCPMC5812628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.